tiprankstipranks
Takeda Pharmaceutical Company (TAK)
NYSE:TAK
US Market

Takeda Pharmaceutical Company (TAK) Cash flow

Compare
1,252 Followers

Takeda Pharmaceutical Company Cash Flow

TAK's free cash flow for Q2 2024 was ¥209.53B. For the 2024 fiscal year, TAK's free cash flow was decreased by ¥-107.85B and operating cash flow was ¥259.00B. See a summary of the company’s cash flow.
Cash Flow
Mar 24Mar 23Mar 22Mar 21Mar 20
Operating Cash Flow
¥ 716.34B¥ 977.16B¥ 1.12T¥ 1.01T¥ 669.75B
Investing Cash Flow
¥ -463.86B¥ -607.10B¥ -198.13B¥ 393.53B¥ 292.12B
Financing Cash Flow
¥ -354.42B¥ -709.15B¥ -1.07T¥ -1.09T¥ -1.01T
End Cash Position
¥ 457.80B¥ 533.53B¥ 849.70B¥ 966.22B¥ 637.61B
Free Cash Flow
¥ 235.61B¥ 343.47B¥ 937.07B¥ 774.46B¥ 452.04B
Currency in JPY

Takeda Pharmaceutical Company Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis